Diss-appointing to see sellers at 2c after a positive announcement but there are buyers for 6 million against sellers of 260K. The continued progression of the cell line is impressive to me especially the reduction in production cost. Somehow I think that the Anavex 2.73A by KaRaMINDS Institute ( I could have this a tad wrong, it could be Anavex their symbol is AVXL) would benefit greatly by being able to utilise the blood brain barrier penetration/crossing capabilities of PAB.
Ann: Appendix 4C - Quarterly - 31 December 2019, page-7
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.40M | |||
| Open | High | Low | Value | Volume |
| 0.7¢ | 0.7¢ | 0.7¢ | $3.875K | 553.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 19 | 3120846 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 1566418 | 1 |
View Market Depth
| Last trade - 13.18pm 05/07/2024 (20 minute delay) ? |
| PAB (ASX) Chart |